health

France sets out proposed medical guidelines for assisted dying

Health authority offers 60 recommendations including specific drugs, training and contingency plans

The recommendations include drugs of choice and additional support networks
Published

France’s independent public health authority has outlined its recommendations to regulate assisted dying in France, including a list of possible drugs to use and the creation of pre-prepared medication kits.

The Haute Autorité de santé (HAS) released its report on Thursday November 19, which includes 60 recommendations for practical implementation of the law.

The assisted dying bill was approved in August by the country’s Constitutional Council and is set to come into force in January 2027.

The report was commissioned by France’s health ministry to identify possible lethal substances that could be used for assisted dying.

The recommendations cover several areas, including administering of the injections, and resources in the event of an accident. 

“We approached this task with the scientific rigour that characterises the HAS,” said authority president Lionel Collet in a press conference about the report, “while maintaining an unwavering commitment to respect, dignity, and careful attention to each individual's unique situation.”

The government is not obliged to take on the authority’s recommendations, but often adheres to advice in its reports.

It is still drafting the decrees that will make up the technical aspects of the law, which can incorporate the HAS recommendations.

‘Peaceful death… in the shortest possible interval’

“The entire process should lead to a peaceful death for the individual, and the lethal substance administered should ensure the shortest possible interval between its administration and death,” said the report.

The HAS focused on the two authorised ways of assisted dying – injections and orally administered medication. 

For the latter, it recommended patients take an anti-emetic (to prevent vomiting) and offering patients an optional anxiolytic (to reduce anxiety). 

It then recommends two medicines, both barbiturates, which induce coma and then death in around 25 minutes. 

For intravenous injections, the HAS recommends two medicines used for general anaesthetics.

Both of these see the patient losing consciousness in under three minutes, followed by respiratory and cardiac arrest. 

If the patient takes anti-anxiety drugs beforehand, dosages should be altered by medical professionals to ensure they remain effective and are able to handle the device themselves. 

Further recommendations

The HAS also recommends that each instance of assisted dying has a contingency plan in place in case there are issues during the process. 

Patients should be given clear instructions and information on the process, including how to administer the drugs. Generally people will administer the injections (or take the tablets themselves) unless physically unable to do so. 

If complications arise, a health expert can administer an additional drug to ensure the patient dies. Even with this intervention, however, the death remains an authorised case of assisted suicide. 

“Should a complication arise or a failure occur, the healthcare professional intervenes… If such an intervention becomes necessary, it is carried out in accordance with the wishes previously expressed by the individual,” said the HAS. 

Everyone involved in assisted dying should be given training on both the “technical and human,” aspects, the HAS added. 

This includes being “trained in listening and engaging in dialogue with the individual and their loved ones,” and providing “support” to loved ones following a person’s death.